Cutler Group’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-5,200
Closed -$6K 4874
2022
Q2
$6K Sell
5,200
-8,900
-63% -$175K ﹤0.01% 3545
2022
Q1
$21K Sell
14,100
-2,600
-16% -$66.3K ﹤0.01% 2996
2021
Q4
$98K Buy
16,700
+9,000
+117% +$367K ﹤0.01% 1866
2021
Q3
$17K Buy
+7,700
New +$345K ﹤0.01% 3476
2021
Q2
Sell
-1,600
Closed -$1K 5628
2021
Q1
$1K Sell
1,600
-6,700
-81% -$399K ﹤0.01% 5117
2020
Q4
$18K Buy
8,300
+500
+6% +$33.9K ﹤0.01% 2741
2020
Q3
$87K Buy
7,800
+4,900
+169% +$243K 0.01% 1412
2020
Q2
$19K Buy
+2,900
New +$100K ﹤0.01% 2404
2017
Q1
Sell
-2,243
Closed -$2K 6320
2016
Q4
$2K Sell
2,243
-13,186
-85% -$197K ﹤0.01% 5541
2016
Q3
$17K Buy
+15,429
New +$498K ﹤0.01% 3574
2016
Q1
Sell
-429
Closed -$2K 6433
2015
Q4
$2K Buy
+429
New +$19.3K ﹤0.01% 5498

Other funds holding ARCT